How to Identify, Treat, and Manage Patients with Multiple Myeloma

 

Rush University Medical Center
S

High-Risk Myeloma: Failures and Future Directions

By Rush University Medical Center FEATURING Saad Usmani
By Rush University Medical Center FEATURING Saad Usmani
71 views
May 27, 2022
0 Comments
Login to view comments. Click here to Login
How to Identify, Treat, and Manage Patients with Multiple Myeloma
05:27
ASH 2021 Conference Coverage on VuMedi

ASH 2021 Sustained Improvement in HRQoL in Transplant-Ineligible Pat…

Feat. A. Perrot
08:55
Laurent Garderet

D-Rd in Transplant-Ineligible NDMM: Results From the MAIA Trial

16:16
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

Frontline Therapy for NDMM: The Role of Transplant, Duration & G…

Feat. A. Krishnan
15:16
SOHO 3rd Italian Conference

SOHO Italy 2021: Newly Diagnosed Transplant-Eligible MM

Feat. V. Montefusco
09:07
ASH 2021 Conference Coverage on VuMedi

ASH 2021: Genomic and Immune Signatures Predict Sustained MRD Negati…

Feat. E. Boyle
19:15
Total Health

Treatment Updates for MM: Risk Stratification's Role in Upfront…

Feat. C. Gleason
18:44
Moffitt Cancer Center's 17th Annual Clinical Breakthroughs & Challenges in Hematologic Malignancies

Moffitt Cancer Center Debate: How Much Is Enough in NDMM - Triplet …

Feat. K. Shain
13:22
SOHO 3rd Italian Conference

SOHO Italy 2021 on the Importance of Imaging in Novel Agents' E…

Feat. E. Zamagni
06:03
UChicago Medicine 7th Annual Updates from ASH 2021

Post-ASH Case Discussion: 59 y/o Male With Blurry Vision and Develop…

Feat. S. Smith, M. Drazer
19:18
Yale Cancer Center

2021 ASH Updates in Smoldering Myeloma and Newly Diagnosed MM

Feat. E. Gorshein
07:15
Ola Landgren

Awareness Around MRD Testing in Myeloma: Why, When, and How to Test

20:17
Rush University Medical Center

High-Risk Myeloma: Failures and Future Directions

Feat. S. Usmani
20:58
Penn Medicine Abramson Cancer Center

Initial Therapy for MM Including Transplant

Feat. A. Garfall
04:29
ecancer

EHA 2022 on a Phase III GMMG-HD7 Trial: Isa-RVd as Induction Therapy…

Feat. E. Mai
31:36
Nebraska Oncology Society

ASCO 2022 on Moving Toward a Cure in Myeloma: The Role of MRD Testing

Feat. A. Nooka